MR spectroscopy may be useful in glioblastoma treatment assessment

07/31/2013 | HealthNewsDigest.com

Researchers at the Winship Cancer Institute of Emory University have been studying ways to assess drug treatment response in glioblastoma patients, and their efforts recently got a boost with a $4 million National Cancer Institute grant. The team has been using magnetic resonance spectroscopy to assess changes in tumor metabolism. "It lets us see something we otherwise couldn't see, something that can help us make best decisions for our patients. Glioblastoma is just an awful disease, and anything that can lighten the burden is tremendously important," said neurosurgeon Dr. Jeffrey Olson.

View Full Article in:

HealthNewsDigest.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ